GLP-1 Supply Issues: Both Companies on Their Toes?
November 3, 2023 — Novo Nordisk and Eli Lilly updated their investors yesterday on their performance through the third quarter of 2023 and the word is that they are “raking in cash” from their new medicines that work so well in obesity. Gobs of money seem to be flowing to both companies, but the stories they were telling about […]
